Hepatic zonation determines tumorigenic potential of mutant β-catenin
Alexander Raven(Cancer Research UK), Owen J. Sansom(Cancer Research UK), June Munro(Cancer Research UK), Peter J. Park(Harvard University), Miryam Müller(Cancer Research UK), Catriona A. Ford(Cancer Research UK), Nikola Vlahov(Cancer Research UK), H. G. HALL(Cancer Research UK), Hu Jin(Harvard University), Thomas G. Bird(MRC Centre for Regenerative Medicine), Sheila Bryson(Cancer Research UK), Kathryn Gilroy(Cancer Research UK Scotland Institute), Colin Nixon(Cancer Research UK), Joseph A. Waldron(Cancer Research UK), Holly Leslie(University of Glasgow), Rachel A. Ridgway(Cancer Research UK Scotland Institute), Nathalie Sphyris(Cancer Research UK), Hans Clevers(Hubrecht Institute for Developmental Biology and Stem Cell Research), Douglas Strathdee(Cancer Research UK), D. Gulhan(Harvard University), Hao Zhu(Fudan University), Nigel B. Jamieson(University of Glasgow), Crispin Miller(Cancer Research UK), Luke Boulter(Edinburgh Cancer Research), Nick Barker(Kanazawa University), Megan L. Mills(Cancer Research UK), Scott H. Waddell(Edinburgh Cancer Research), Rachel V. Guest(Edinburgh Royal Infirmary), Barbara Cadden(Cancer Research UK), E. S. Anderson(Cancer Research UK), Martin Bushell(Cancer Research UK), Andrew Hartley(University of Glasgow), Stephanie May(Cancer Research UK)
Cited by 5